LYKA LABS
Back to Cashflow Statement
|
LYKA LABS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹0.02 Cr | ₹-4.60 Cr | ₹-5.76 Cr | ₹-5.34 Cr | ₹9.90 Cr |
What is the latest Net Cash Inflow / Outflow ratio of LYKA LABS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹0.02 Cr |
| Mar2025 | ₹-4.60 Cr |
| Mar2024 | ₹-5.76 Cr |
| Mar2023 | ₹-5.34 Cr |
| Mar2022 | ₹9.90 Cr |
How is Net Cash Inflow / Outflow of LYKA LABS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹0.02 Cr | Positive | |
| Mar2025 | ₹-4.60 Cr | Negative | |
| Mar2024 | ₹-5.76 Cr | Negative | |
| Mar2023 | ₹-5.34 Cr | Negative | |
| Mar2022 | ₹9.90 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹244.8 Cr | 6.9% | -5.8% | -39.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 6.9% |
-5.8% |
-39.4% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses